Skip to main content
Clinical Trials/CTRI/2024/07/071651
CTRI/2024/07/071651
Not yet recruiting
Phase 4

A Comparitive Study to Evaluate The Efficacy and Safety of Injection Labetalol Versus Tablet Nifedipine in patients of Severe pre-eclampsia in Tertiary care centre. - NI

DrRida Rizvi0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: O141- Severe pre-eclampsia
Sponsor
DrRida Rizvi
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
DrRida Rizvi

Eligibility Criteria

Inclusion Criteria

  • Women with Viable fetus at 20 weeks of gestation or more with severe pre\-eclampsia

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials